Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02191605 · ClinicalTrials.gov registry record · NA

Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy

A NA study, sponsored by Wayne State University.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT02191605: Completed NA study, sponsored by Wayne State University.

NCT02191605 is a NA study that has completed, run by Wayne State University. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02191605, a NA study, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

Marijuana is by far the mostly commonly used illicit drug during pregnancy, and prenatal exposure to marijuana can have lasting negative effects. However, current answers to this problem are failing to reach most women who use marijuana while pregnant. This project will develop and begin testing two technology-based, highly practical interventions that could reduce the number of children who are prenatally exposed to marijuana.

Primary Outcome

Marijuana use will be measured at the time of delivery of their infant by self-report (TimeLine Follow Back interview - TLFB) and urine analysis. This will represent the number of participants who abstinent (reported no marijuana use and had a negative toxicology urine screen) from marijuana for the 7 days prior to delivery.

Interventions

  • BEHAVIORAL eSBIRT
  • BEHAVIORAL Tailored texting

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2015-09-30
Est. Completion 2017-10-27
Phase NA
Wayne State University

163 total trials

What the finished NCT02191605 record still lists

NCT02191605 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which eSBIRT is the first listed.

NCT02191605 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02191605 about?

NCT02191605 is a clinical study titled "Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy". Marijuana is by far the mostly commonly used illicit drug during pregnancy, and prenatal exposure to marijuana can have lasting negative effects. However, current answers to this problem are failing to reach most women who use marijuana while pregnant. This project will develop and begin testing two...

What is the current status of trial NCT02191605?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2015-09-30. Estimated completion is 2017-10-27.

What interventions are being tested in trial NCT02191605?

The interventions under investigation include: eSBIRT (BEHAVIORAL), Tailored texting (BEHAVIORAL).

Who is sponsoring clinical trial NCT02191605?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02191605's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02191605, the US trial registry maintained by the National Library of Medicine. NCT02191605 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.